Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Lin Hsieh

Showing results (251-260 of 258) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 258 results.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modalityJule Goike, Ching-Lin Hsieh, Andrew Horton, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Science Translational Medicine|April 6, 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Pageof 26

Showing results (251-260 of 258) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modalityJule Goike, Ching-Lin Hsieh, Andrew Horton, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Science Translational Medicine|April 6, 2021
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Pageof 26